Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease

被引:35
作者
Guo, Yu-Lin [1 ,2 ]
Duan, Wen-Jun [1 ,2 ]
Lu, Dan-Hua [1 ,2 ]
Ma, Xiao-Hui [1 ,2 ]
Li, Xiao-Xiao [1 ,2 ]
Li, Zhao [1 ,2 ]
Bi, Wei [3 ]
Kurihara, Hiroshi [1 ,2 ]
Liu, Hai-Zhi [3 ]
Li, Yi-Fang [1 ,2 ]
He, Rong-Rong [1 ,2 ,4 ]
机构
[1] Jinan Univ, Guangdong Engn Res Ctr Chinese Med & Dis Suscepti, Guangzhou 510632, Peoples R China
[2] Jinan Univ, Coll Pharm, Int Cooperat Lab Tradit Chinese Med Modernizat &, Chinese Minist Educ MOE, Guangzhou 510632, Peoples R China
[3] Jinan Univ, Affiliated Hosp 1, Guangzhou 510632, Peoples R China
[4] Jinan Univ, Sch Chinese Med, Integrated Chinese & Western Med Dept, Guangzhou 510632, Peoples R China
来源
ACTA PHARMACOLOGICA SINICA | 2021年 / 42卷 / 04期
基金
中国国家自然科学基金;
关键词
Parkinson's disease; GM1; ganglioside; alpha-synuclein; autophagy; dopamine; DOPAMINE NEURONS; MITOCHONDRIAL DYSFUNCTION; ENHANCED AUTOPHAGY; UP-REGULATION; ULK1; COMPLEX; CELL-DEATH; MODELS; DEGRADATION; LEVODOPA; MUTATION;
D O I
10.1038/s41401-020-0454-y
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
GM1 ganglioside is particularly abundant in the mammalian central nervous system and has shown beneficial effects on neurodegenerative diseases. In this study, we investigated the therapeutic effect of GM1 ganglioside in experimental models of Parkinson's disease (PD) in vivo and in vitro. Mice were injected with MPTP (30 mg center dot kg(-1)center dot d(-1), i.p.) for 5 days, resulting in a subacute model of PD. PD mice were treated with GM1 ganglioside (25, 50 mg center dot kg(-1)center dot d(-1), i.p.) for 2 weeks. We showed that GM1 ganglioside administration substantially improved the MPTP-induced behavioral disturbance and increased the levels of dopamine and its metabolites in the striatal tissues. In the MPP+-treated SH-SY5Y cells and alpha-synuclein (alpha-Syn) A53T-overexpressing PC12 (PC12(alpha-Syn A53T)) cells, treatment with GM1 ganglioside (40 mu M) significantly decreased alpha-Syn accumulation and alleviated mitochondrial dysfunction and oxidative stress. We further revealed that treatment with GM1 ganglioside promoted autophagy, evidenced by the autophagosomes that appeared in the substantia nigra of PD mice as well as the changes of autophagy-related proteins (LC3-II and p62) in the MPP+-treated SH-SY5Y cells. Cotreatment with the autophagy inhibitor 3-MA or bafilomycin A1 abrogated the in vivo and in vitro neuroprotective effects of GM1 ganglioside. Using GM1 ganglioside labeled with FITC fluorescent, we observed apparent colocalization of GM1-FITC and alpha-Syn as well as GM1-FITC and LC3 in PC12(alpha-Syn A53T)cells. GM1 ganglioside significantly increased the phosphorylation of autophagy regulatory proteins ATG13 and ULK1 in doxycycline-treated PC12(alpha-Syn A53T)cells and the MPP+-treated SH-SY5Y cells, which was inhibited by 3-MA. Taken together, this study demonstrates that the anti-PD role of GM1 ganglioside resulted from activation of autophagy-dependent alpha-Syn clearance.
引用
收藏
页码:518 / 528
页数:11
相关论文
共 66 条
[1]   GANGLIOSIDES INCREASE THE SURVIVAL OF LESIONED NIGRAL DOPAMINE NEURONS AND FAVOR THE RECOVERY OF DOPAMINERGIC SYNAPTIC FUNCTION IN STRIATUM OF RATS BY COLLATERAL SPROUTING [J].
AGNATI, LF ;
FUXE, K ;
CALZA, L ;
BENFENATI, F ;
CAVICCHIOLI, L ;
TOFFANO, G ;
GOLDSTEIN, M .
ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 119 (04) :347-363
[2]   Anti-Parkinson Activity of Petroleum Ether Extract of Ficus religiosa (L.) Leaves [J].
Bhangale, Jitendra O. ;
Acharya, Sanjeev R. .
ADVANCES IN PHARMACOLOGICAL SCIENCES, 2016, 2016
[3]   Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models [J].
Bibbiani, F ;
Oh, JD ;
Chase, TN .
NEUROLOGY, 2001, 57 (10) :1829-1834
[4]   Fighting neurodegeneration with rapamycin: mechanistic insights [J].
Bove, Jordi ;
Martinez-Vicente, Marta ;
Vila, Miquel .
NATURE REVIEWS NEUROSCIENCE, 2011, 12 (08) :437-452
[5]   Nondopaminergic mechanisms in levodopa-induced dyskinesia [J].
Brotchie, JA .
MOVEMENT DISORDERS, 2005, 20 (08) :919-931
[6]   Therapeutic approaches to target alpha-synuclein pathology [J].
Brundin, Patrik ;
Dave, Kuldip D. ;
Kordower, Jefft Ey H. .
EXPERIMENTAL NEUROLOGY, 2017, 298 :225-235
[7]   Regulation and Function of Uncoordinated-51 Like Kinase Proteins [J].
Chan, Edmond Y. .
ANTIOXIDANTS & REDOX SIGNALING, 2012, 17 (05) :775-785
[8]   Corynoxine, a Natural Autophagy Enhancer, Promotes the Clearance of Alpha-Synuclein via Akt/mTOR Pathway [J].
Chen, Lei-Lei ;
Song, Ju-Xian ;
Lu, Jia-Hong ;
Yuan, Zhen-Wei ;
Liu, Liang-Feng ;
Durairajan, Siva Sundara Kumar ;
Li, Min .
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2014, 9 (03) :380-387
[9]   Enhanced Autophagy Contributes to Protective Effects of GM1 Ganglioside Against Aβ1-42-Induced Neurotoxicity and Cognitive Deficits [J].
Dai, Ruwei ;
Zhang, Shijie ;
Duan, Wenjun ;
Wei, Renrong ;
Chen, Huifang ;
Cai, Weibin ;
Yang, Lei ;
Wang, Qi .
NEUROCHEMICAL RESEARCH, 2017, 42 (08) :2417-2426
[10]   Epidemiology of Parkinson's disease [J].
de Lau, Lonneke M. L. ;
Breteler, Monique M. B. .
LANCET NEUROLOGY, 2006, 5 (06) :525-535